Cervomed to participate in the emerging growth conference

Boston, july 17, 2024 (globe newswire) -- cervomed inc. (nasdaq: crvo), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced that company's management will present virtually at the emerging growth conference.
CRVO Ratings Summary
CRVO Quant Ranking